JFrog stock rises as Cantor Fitzgerald maintains Overweight rating after strong Q2
NEW YORK/LEAMINGTON, Ontario - Cannabis and consumer goods company Tilray Brands, Inc. (NASDAQ:TLRY; TSX:TLRY), currently trading at $1.25 with a market capitalization of $1.37 billion, has applied for an extension to regain compliance with Nasdaq’s minimum share price requirements, according to a press release issued Thursday.
The company is considering several options to address its capital structure, including a potential stockholder-approved reverse stock split to maintain its Nasdaq listing.
CEO Irwin Simon noted that Tilray’s stock has recently appreciated following President Trump’s review of cannabis rescheduling, which he suggested reflects investor confidence in the company’s diversified global platform.
"Tilray has multiple options to meet Nasdaq’s requirements, and with this extension request, we are giving the market additional time to demonstrate its confidence in our long-term strategy," Simon said in the statement.
Nasdaq listing rules typically require listed companies to maintain a minimum bid price of $1.00 per share. Companies failing to meet this requirement for 30 consecutive business days receive notification and are generally given 180 calendar days to regain compliance.
Tilray describes itself as a global lifestyle consumer packaged goods company operating across cannabis, beverage, and wellness sectors with a presence in Canada, the United States, Europe, Australia, and Latin America.
The company’s portfolio includes over 40 brands in more than 20 countries, according to the press release.
In other recent news, Tilray Inc. reported its fourth-quarter 2025 financial results, revealing a mixed performance. The company achieved earnings per share of $0.02, which exceeded analyst expectations of -$0.02. However, Tilray’s revenue fell short, recording $224.5 million compared to the projected $247.02 million, a 9.12% miss. Despite the revenue shortfall, Jefferies maintained its Buy rating for Tilray, setting a price target of $1.50. Jefferies attributed the revenue miss to factors such as soft beer demand and delays in cannabis shipments. In a broader industry context, Tilray’s stock, along with other cannabis companies, saw gains after reports that President Trump is considering reclassifying marijuana as a less dangerous drug. This potential regulatory shift could significantly impact the cannabis sector. These developments highlight the dynamic nature of the cannabis industry, with both challenges and opportunities on the horizon.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.